Vontobel Holding’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Vontobel Holding’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-35,800	Closed	-$15K	–	1455
2025 Q4	$15K	Sell	35,800 -31,600	-47%	-$16.8K	﹤0.01%	1427
2025 Q3	$45.4K	Buy	67,400 +14,400	+27%	+$7.76K	﹤0.01%	1330
2025 Q2	$28.7K	Buy	+53,000	New	+$31.5K	﹤0.01%	1251

Other funds holding SGMO

AIM

Axiom Investment Management New York $150M AUM

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Vontobel Holding's SGMO Position: Q2 2026 in Review

Vontobel Holding sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 120,000 shares — an estimated $29.6K sold.

Vontobel Holding first reported a position in SGMO in Q4 2020 and held it in 22 quarters. The position peaked at $321K in Q4 2020. 2 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

Vontobel Holding reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
Vontobel Holding sold 120,000 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $29.6K.
Vontobel Holding first reported a position in SANGAMO THERAPEUTICS INC in Q4 2020 and held it in 22 quarters.
Vontobel Holding's SANGAMO THERAPEUTICS INC position peaked at $321K in Q4 2020.
2 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.